| A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants. | 20522170 | PMC2955175 | Journal | 2011 | 10.1111/j.1399-5448.2010.00662.x | DPT-1 | | Contributing Study |
| A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants. | 21911777 | PMC3198298 | Journal | 2011 | 10.2337/dc11-0981 | DPT-1 | | Contributing Study |
| A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1. | 18000175 | | Journal | 2008 | 10.2337/dc07-1459 | DPT-1 | | Contributing Study |
| Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies. | 21843518 | PMC5839139 | Journal | 2011 | 10.1016/j.cca.2011.07.019 | DPT-1 | | Contributing Study |
| Development of autoantibodies in the TrialNet Natural History Study. | 21750277 | PMC3161292 | Journal | 2011 | 10.2337/dc11-0560 | DPT-1 | | Contributing Study |
| Diabetes Prevention Trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband. | 12021118 | | Journal | 2002 | | DPT-1 | | Contributing Study |
| Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. | 19407074 | PMC2671125 | Journal | 2009 | 10.2337/dc08-1872 | DPT-1 | | Contributing Study |
| Effect of low-dose insulin treatment on body weight and physical development in children and adolescents at risk for type 1 diabetes. | 16043737 | | Journal | 2005 | 10.2337/diacare.28.8.1948 | DPT-1 | | Contributing Study |
| Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study. | 17583798 | | Journal | 2007 | 10.1007/s00125-007-0694-0 | DPT-1 | | Contributing Study |
| Effects of insulin in relatives of patients with type 1 diabetes mellitus. | 12037147 | | Journal | 2002 | 10.1056/NEJMoa012350 | DPT-1 | | Contributing Study |
| Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. | 15855569 | | Journal | 2005 | 10.2337/diacare.28.5.1068 | DPT-1 | | Contributing Study |
| Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. | 11473032 | | Journal | 2001 | 10.2337/diabetes.50.8.1735 | DPT-1 | | Contributing Study |
| Expression of beta-cell autoimmunity does not differ between potential dizygotic twins and siblings of patients with type 1 diabetes. | 15501398 | | Journal | 2004 | 10.1016/j.jaut.2004.07.001 | DPT-1 | | Contributing Study |
| First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. | 11174623 | | Journal | 2001 | 10.1067/mpd.2001.111274 | DPT-1 | | Contributing Study |
| Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1. | 18650369 | PMC2571043 | Journal | 2008 | 10.2337/dc08-0935 | DPT-1 | | Contributing Study |
| Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1). | 20682683 | PMC3279562 | Journal | 2010 | 10.2337/db10-0534 | DPT-1 | | Contributing Study |
| High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 Diabetes. | 15602651 | | Journal | 2005 | 10.1007/s00125-004-1608-z | DPT-1 | | Contributing Study |
| Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). | 18556337 | PMC2518486 | Journal | 2008 | 10.2337/db07-1736 | DPT-1 | | Contributing Study |
| Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1. | 19487644 | PMC2732147 | Journal | 2009 | 10.2337/dc08-2140 | DPT-1 | | Contributing Study |
| Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1. | 17192330 | | Journal | 2007 | 10.2337/dc06-1615 | DPT-1 | | Contributing Study |
| Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood. | 21270193 | PMC3024349 | Journal | 2011 | 10.2337/dc10-1494 | DPT-1 | | Contributing Study |
| Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1. | 10720072 | | Journal | 2000 | 10.1210/jcem.85.3.6459 | DPT-1 | | Contributing Study |
| Male sex increases the risk of autoimmunity but not type 1 diabetes. | 15277428 | | Journal | 2004 | 10.2337/diacare.27.8.1985 | DPT-1 | | Contributing Study |
| Metabolic Characteristics of Converters to ICA Positivity in the Diabetes Prevention Trial-Type 1 (DPT-1). | | | Journal | 2007 | | DPT-1 | | Contributing Study |
| PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. | 17976390 | PMC3057075 | Journal | 2008 | 10.1016/j.freeradbiomed.2007.09.013 | DPT-1 | | Contributing Study |
| Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. | 19741189 | PMC2782989 | Journal | 2009 | 10.2337/dc09-0934 | DPT-1 | | Contributing Study |
| Parenteral insulin suppresses T cell proliferation to islet antigens. | 20522167 | PMC2957543 | Journal | 2011 | 10.1111/j.1399-5448.2010.00674.x | DPT-1 | | Contributing Study |
| Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes. | 18823410 | PMC4206940 | Journal | 2009 | 10.1111/j.1399-5448.2008.00463.x | DPT-1 | | Contributing Study |
| Participant and parent experiences in the parenteral insulin arm of the diabetes prevention trial for type 1 diabetes. | 17563348 | | Journal | 2007 | 10.2337/dc06-2422 | DPT-1 | | Contributing Study |
| Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. | 16505520 | | Journal | 2006 | 10.2337/diacare.29.03.06.dc05-1006 | DPT-1 | | Contributing Study |
| Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing. | 17188609 | PMC1868416 | Journal | 2007 | 10.1016/j.jpeds.2006.09.033 | DPT-1 | | Contributing Study |
| Prevention of type 1 diabetes: the time has come. | 18446141 | | Journal | 2008 | 10.1038/ncpendmet0832 | DPT-1 | | Contributing Study |
| Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. | 20807869 | PMC2992179 | Journal | 2010 | 10.2337/dc10-0802 | DPT-1 | | Contributing Study |
| Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. | 20028949 | PMC2828663 | Journal | 2010 | 10.2337/db09-1378 | DPT-1 | | Contributing Study |
| Role of insulin resistance in predicting progression to type 1 diabetes. | 17536068 | | Journal | 2007 | 10.2337/dc06-2389 | DPT-1 | | Contributing Study |
| Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. | 12519837 | | Journal | 2003 | 10.1210/jc.2002-020760 | DPT-1 | | Contributing Study |
| Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. | 16464953 | | Journal | 2006 | 10.1210/jc.2005-1695 | DPT-1 | | Contributing Study |
| T1dCteGui: A User-Friendly Clinical Trial Enrichment Tool to Optimize Type-1 Diabetes Prevention Studies by Leveraging AI/ML based Synthetic Patient Population | 37326252 | | Journal | 2023 | 10.1002/cpt.2976 | DPT-1, TN10, TN07, TEDDY, TN01 | 21437 | Secondary Research |
| Thalamic Neuronal Dysfunction in Diabetic Peripheral Neuropathy. | | | Conference Presentation | 2007 | | DPT-1 | | Contributing Study |
| The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. | 12203941 | | Journal | 2002 | 10.1002/dmrr.316 | DPT-1 | | Contributing Study |
| The Diabetes Prevention Trial-Type 1 diabetes (DPT-1): implementation of screening and staging of relatives. DPT-1 Study Group. | 8540003 | | Journal | 1995 | | DPT-1 | | Contributing Study |
| The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. | 18823409 | | Journal | 2009 | 10.1111/j.1399-5448.2008.00464.x | DPT-1 | | Contributing Study |
| The rise and fall of insulin secretion in type 1 diabetes mellitus. | 16404554 | | Journal | 2006 | 10.1007/s00125-005-0100-8 | DPT-1 | | Contributing Study |
| Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants. | 20032282 | PMC2827520 | Journal | 2010 | 10.2337/dc09-1770 | DPT-1 | | Contributing Study |
| Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. | 11272162 | | Journal | 2001 | 10.2337/diabetes.50.2.470 | DPT-1 | | Contributing Study |
| Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. | 21680724 | PMC3142063 | Journal | 2011 | 10.2337/dc11-0641 | DPT-1 | | Contributing Study |
